Ausgabe 3/2014
Inhalt (21 Artikel)
Prognosis of synchronous bilateral breast cancer: a review and meta-analysis of observational studies
Marianne Holm, Anne Tjønneland, Eva Balslev, Niels Kroman
Leptomeningeal disease and breast cancer: the importance of tumor subtype
Sausan Abouharb, Joe Ensor, Monica Elena Loghin, Ruth Katz, Stacy L. Moulder, Francisco J. Esteva, Benjamin Smith, Vicente Valero, Gabriel N. Hortobagyi, Amal Melhem-Bertrandt
Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer
Meiyun Fan, Aarti Sethuraman, Martin Brown, Wenlin Sun, Lawrence M. Pfeffer
Association study of susceptibility loci with specific breast cancer subtypes in Chinese women
Bo Zhang, Yang Li, Longnian Li, Mengyun Chen, Cuicui Zhang, Xian-bo Zuo, Fu-sheng Zhou, Bo Liang, Jun Zhu, Pan Li, Zhong-lian Huang, Han Xuan, Wei Li, Zhen-dong Chen
RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase
Hong Hu, Jun Wang, Akash Gupta, Ali Shidfar, Daniel Branstetter, Oukseub Lee, David Ivancic, Megan Sullivan, Robert T. Chatterton Jr., William C. Dougall, Seema A. Khan
Metabolic differences in breast cancer stem cells and differentiated progeny
Erina Vlashi, Chann Lagadec, Laurent Vergnes, Karen Reue, Patricia Frohnen, Mabel Chan, Yazeed Alhiyari, Milana Bochkur Dratver, Frank Pajonk
RETRACTED ARTICLE: Inhibition of breast cancer metastasis with microRNA-302a by downregulation of CXCR4 expression
Zhongxing Liang, Xuehai Bian, Hyunsuk Shim
Notch2 activation is protective against anticancer effects of zerumbone in human breast cancer cells
Anuradha Sehrawat, Kozue Sakao, Shivendra V. Singh
TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases
Carey Anders, Allison M. Deal, Vandana Abramson, Minetta C. Liu, Anna M. Storniolo, John T. Carpenter, Shannon Puhalla, Rita Nanda, Amal Melhem-Bertrandt, Nancy U. Lin, P. Kelly Marcom, Catherine Van Poznak, Vered Stearns, Michelle Melisko, J. Keith Smith, Olga Karginova, Joel Parker, Jonathan Berg, Eric P. Winer, Amy Peterman, Aleix Prat, Charles M. Perou, Antonio C. Wolff, Lisa A. Carey
Platinum-based chemotherapy in triple-negative advanced breast cancer
Cynthia Villarreal-Garza, Daniel Khalaf, Nathaniel Bouganim, Mark Clemons, Omar Peña-Curiel, Berenice Baez-Revueltas, Alexander Kiss, Farah Kassam, Katherine Enright, Sunil Verma, Kathleen Pritchard, Jeff Myers, Rebecca Dent
Prognostic relevance of peritumoral vascular invasion in immunohistochemically defined subtypes of node-positive breast cancer
Elisabetta Munzone, Vincenzo Bagnardi, Nicole Rotmensz, Andrea Sporchia, Manuelita Mazza, Giancarlo Pruneri, Mattia Intra, Angela Sciandivasci, Oreste Gentilini, Alberto Luini, Giuseppe Viale, Paolo Veronesi, Marco Colleoni
Breast cancer and bone metastases: the association of axial skeleton MRI findings with skeletal-related events and survival
Christian B. van der Pol, Mark E. Schweitzer, Gina Di Primio, Marcos L. Sampaio, Ania Kielar, Mark Clemons, Arash Jaberi
Choosing relevant endpoints for older breast cancer patients in clinical trials: an overview of all current clinical trials on breast cancer treatment
N. A. de Glas, M. E. Hamaker, M. Kiderlen, A. J. M. de Craen, S. P. Mooijaart, C. J. H. van de Velde, B. C. van Munster, J. E. A. Portielje, G. J. Liefers, E. Bastiaannet
Long-term cognitive function change among breast cancer survivors
Ying Zheng, Jianfeng Luo, Pingping Bao, Hui Cai, Zhen Hong, Ding Ding, James C. Jackson, Xiao-Ou Shu, Qi Dai
Adolescent physical activity and inactivity: a prospective study of risk of benign breast disease in young women
Catherine S. Berkey, Rulla M. Tamimi, Walter C. Willett, Bernard Rosner, A. Lindsay Frazier, Graham A. Colditz
Cardiac glycosides and the risk of breast cancer in women with chronic heart failure and supraventricular arrhythmia
Sébastien Couraud, Sophie Dell’Aniello, Nathaniel Bouganim, Laurent Azoulay
Differences in metastatic patterns in relation to time between primary surgery and first relapse from breast cancer suggest synchronized growth of dormant micrometastases
Hanna Dillekås, Monica Transeth, Martin Pilskog, Jörg Assmus, Oddbjørn Straume
Prevalence of women with early-stage breast cancer receiving active management using electronic health records from oncology clinics in the United States
Rohini K. Hernandez, David Quach, Sally W. Wade, Melissa Pirolli, Jane Quigley, Steven A. Narod, Alexander Liede
Central adiposity after breast cancer diagnosis is related to mortality in the Health, Eating, Activity, and Lifestyle study
Stephanie M. George, Leslie Bernstein, Ashley W. Smith, Marian L. Neuhouser, Kathy B. Baumgartner, Richard N. Baumgartner, Rachel Ballard-Barbash
ERβ splice variant expression in four large cohorts of human breast cancer patient tumors
Hallie Wimberly, Gang Han, Dushanthi Pinnaduwage, Leigh C. Murphy, Xiaohong Rose Yang, Irene L. Andrulis, Mark Sherman, Jonine Figueroa, David L. Rimm
Using quality-adjusted progression-free survival as an outcome measure to assess the benefits of cancer drugs in randomized-controlled trials: case of the BOLERO-2 trial
Vakaramoko Diaby, Georges Adunlin, Askal Ayalew Ali, Rima Tawk